非普拉宗 T7722
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
1 mg | 30748-29-9 | ¥163.00 | 询底价 |
500 mg | 30748-29-9 | ¥4,560.00 | 询底价 |
25 mg | 30748-29-9 | ¥857.00 | 询底价 |
50 mg | 30748-29-9 | ¥1,260.00 | 询底价 |
5 mg | 30748-29-9 | ¥358.00 | 询底价 |
100 mg | 30748-29-9 | ¥1,870.00 | 询底价 |
10 mg | 30748-29-9 | ¥518.00 | 询底价 |
1 mL | 30748-29-9 | ¥150.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Feprazone
描述: Feprazone (DA-2370) 具有抗炎和抗脂肪生成特性。 Feprazone 可用于治疗关节和肌肉疼痛的研究。
体外活性: Lipid accumulation, elevated production of triglycerides, the release of glycerol, upregulated SREBP-1C, FABP4, PPAR-γ, and C/EBP-α and downregulated ATGL and AQP-7 in the 3 T3-L1 adipocytes induced by the adipocyte differentiation cocktail medium were significantly reversed by treatment with Feprazone(30 and 60 μM)[1].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 27.5 mg/mL (85.83 mM)
关键字: Feprazone
相关库: Antioxidant Compound Library | Drug Repurposing Compound Library | Approved Drug Library | ReFRAME Related Library | FDA-Approved & Pharmacopeia Drug Library | Bioactive Compounds Library Max | Human Metabolite Library | Orally Active Compound Library | Bioactive Compound Library
非普拉宗 T7722信息由TargetMol中国为您提供,如您想了解更多关于非普拉宗 T7722报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途